Arialys Therapeutics, Inc.

Biotechnology company · La Jolla, California, United States

Arialys Therapeutics, Inc. is a biotechnology company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Arialys Therapeutics at a glance

Typebiotechnology company
HeadquartersLa Jolla, California, United States
Earliest incorporation on record2021
SEC CIK1956823

What does Arialys Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $14.8 million sold (2025).

Frequently asked questions about Arialys Therapeutics

Where is Arialys Therapeutics headquartered?

Arialys Therapeutics, Inc. is headquartered in La Jolla, California, United States.

What does Arialys Therapeutics do?

Arialys Therapeutics, Inc. is a biotechnology company.

When was Arialys Therapeutics founded?

The earliest incorporation on record for Arialys Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences